Follow
zhao wenfeng
zhao wenfeng
Shanghai Institute of Materia Medica
Verified email at simm.ac.cn
Title
Cited by
Cited by
Year
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
W Yin, C Mao, X Luan, DD Shen, Q Shen, H Su, X Wang, F Zhou, W Zhao, ...
Science 368 (6498), 1499-1504, 2020
12802020
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
H Su, S Yao, W Zhao, M Li, J Liu, W Shang, H Xie, C Ke, H Hu, M Gao, ...
Acta Pharmacologica Sinica 41 (9), 1167-1177, 2020
4152020
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
H Su, S Yao, W Zhao, Y Zhang, J Liu, Q Shao, Q Wang, M Li, H Xie, ...
Nature communications 12 (1), 3623, 2021
1692021
What coronavirus 3C‐like protease tells us: from structure, substrate selectivity, to inhibitor design
M Xiong, H Su, W Zhao, H Xie, Q Shao, Y Xu
Medicinal Research Reviews 41 (4), 1965-1998, 2021
942021
N-Substituted 3(10H)-Acridones as Visible-Light, Water-Soluble Photocatalysts: Aerobic Oxidative Hydroxylation of Arylboronic Acids
HY Xie, LS Han, S Huang, X Lei, Y Cheng, W Zhao, H Sun, X Wen, QL Xu
The Journal of organic chemistry 82 (10), 5236-5241, 2017
722017
In silico screening-based discovery of novel inhibitors of human cyclic GMP–AMP synthase: a cross-validation study of molecular docking and experimental testing
W Zhao, M Xiong, X Yuan, M Li, H Sun, Y Xu
Journal of Chemical Information and Modeling 60 (6), 3265-3276, 2020
532020
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir
X Jiang, H Su, W Shang, F Zhou, Y Zhang, W Zhao, Q Zhang, H Xie, ...
Nature Communications 14 (1), 6463, 2023
512023
Construction of Oxadiazepines via Lewis Acid-Catalyzed Tandem 1, 5-Hydride Shift/Cyclization
YZ Chang, ML Li, WF Zhao, X Wen, H Sun, QL Xu
The Journal of Organic Chemistry 80 (19), 9620-9627, 2015
412015
Fragment-based discovery of novel pentacyclic triterpenoid derivatives as cholesteryl ester transfer protein inhibitors
Y Chang, S Zhou, E Li, W Zhao, Y Ji, X Wen, H Sun, H Yuan
European journal of medicinal chemistry 126, 143-153, 2017
212017
Discovery of ubiquitin-specific protease 7 (USP7) Inhibitors with novel scaffold structures by virtual screening, molecular dynamics simulation, and biological evaluation
S Liu, X Zhou, M Li, W Zhao, S Zhou, K Cheng, Q Xu, C Chen, X Wen, ...
Journal of chemical information and modeling 60 (6), 3255-3264, 2020
182020
Identification of Cysteine 270 as a Novel Site for Allosteric Modulators of SARS‐CoV‐2 Papain‐Like Protease
H Hu, Q Wang, H Su, Q Shao, W Zhao, G Chen, M Li, Y Xu
Angewandte Chemie International Edition 61 (52), e202212378, 2022
112022
Discovery of novel nucleotide prodrugs with improved potency against HCV variants carrying NS5B S282T mutation
L Zhen, L Dai, X Wen, L Yao, X Jin, XW Yang, W Zhao, SQ Yu, H Yuan, ...
Journal of Medicinal Chemistry 60 (14), 6077-6088, 2017
102017
Discovery of novel cGAS inhibitors based on natural flavonoids
J Li, M Xiong, J Liu, F Zhang, M Li, W Zhao, Y Xu
Bioorganic Chemistry 140, 106802, 2023
62023
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors
X Wang, L Xiong, Y Zhu, S Liu, W Zhao, X Wu, M Seydimemet, L Li, ...
Journal of the American Chemical Society, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–14